Sign inJoin waitlistJoin the waitlist

PS

Paul Swiecicki

Physician · University of Michigan Health-Ann Arbor

Credentials: · · · ·

History

University of Michigan Health-Ann Arbor
Present

Medical Oncology
2014–2016
Internal Medicine
2011–2014
Michigan State University College of Human Medicine
2007–2011

Research

Management of Salivary Gland Malignancy: ASCO Guideline
Journal of Clinical Oncology · 2021 · 356 citations
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma
New England Journal of Medicine · 2022 · 277 citations
Pembrolizumab plus cetuximab in patients with recurrent or metastatic head and neck squamous cell carcinoma: an open-label, multi-arm, non-randomised, multicentre, phase 2 trial
The Lancet Oncology · 2021 · 228 citations

MS
Matthew Spector
48 papers
FW
Francis Worden
44 papers
MM
Michelle Mierzwa
38 papers
Mark Prince
36 papers
Andrew Shuman
35 papers
Keith Casper
33 papers
Kelly Malloy
33 papers
SC
Steven Chinn
31 papers
Chaz Stucken
26 papers
Carol Bradford
23 papers
AR
Andrew Rosko
19 papers · 1 as a resident
Jennifer Shah
19 papers

Clinical trials

Combined Amivantamab, Carboplatin and Paclitaxel in Unresectable Locally Recurrent or Metastatic Head and Neck Cancer
Principal investigator · Enrolling by invitation · Phase 2
SWOG Cancer Research Network
2026–2029
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
Principal investigator · Suspended · Phase 2
National Cancer Institute (NCI)
2026–2029
Ivonescimab Before Surgery for the Treatment of Resectable Stage II-IV Head and Neck Cancer
Principal investigator · Recruiting · Phase 2
University of Michigan Rogel Cancer Center
2025–2030
APG-115 in Salivary Gland Cancer Trial
Principal investigator · Active not recruiting · Phase 1, Phase 2
University of Michigan Rogel Cancer Center
2019–2027